サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701246

診断における人工知能の市場規模、シェア、動向分析レポート：コンポーネント別、診断別、地域別、セグメント予測、2025年～2030年

Artificial Intelligence In Diagnostics Market Size, Share & Trends Analysis Report By Component, By Diagnosis, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
診断における人工知能の市場規模、シェア、動向分析レポート：コンポーネント別、診断別、地域別、セグメント予測、2025年～2030年
出版日: 2025年03月03日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

診断における人工知能市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、診断における人工知能の世界市場規模は2030年に54億4,000万米ドルに達し、予測期間中にCAGR 22.46％で成長すると予測されています。

正確で精度の高い診断を早期に提供し、臨床的・業務的成果を高めるために、AI対応アルゴリズムを診断に統合する需要の高まりが、この市場の成長を促進しています。世界中で急性・慢性疾患の症例が急増しており、これらの疾患のほとんどは、早期に診断して適切な治療を行えば、予防または遅らせることができるため、AIベースのソリューションに対する需要が高まっています。ヘルスケア人材の不足も製品需要を支えています。

新興企業の出現、資金調達機会の増加、官民連携の拡大も市場の成長を後押ししています。さらに、医療技術は大きな転換期を迎えており、医療提供者が適切な治療計画を立案できるような正確な診断を提供するために、高度なAIを搭載したソリューションを急速に採用しています。放射線学と病理学は、AIベースのアルゴリズムとソリューションを広く導入しており、実証済みの結果を提供しています。放射線学では、これらのソリューションは複数のモダリティから収集した情報を使用して画像データセットを作成し、データ解析を実行します。同様に病理学においても、これらのソリューションを統合してデータ解析を実行し、正確な結果を提供することができます。

世界人口の慢性疾患負担の増大も、AIベースの診断ソリューションの需要を促進しています。診断におけるAI市場の主な参入企業は、他社に対する競争優位性を獲得するため、革新的な新製品の開発と事業提供の拡大に注力しています。また、AIベースの先端技術開発を専門とする新興企業の多くが、好意的な支援や資金調達の機会を得ています。これも市場全体の成長に好影響を与えると思われます。例えば、2018年9月、IDxはOptum Venturesと8VCから3,300万米ドルの資金提供を受け、同社はこの資金を革新的なAIベースのソリューション開発に使用する予定です。

診断における人工知能市場レポートハイライト

  • 早期かつ正確な疾患検出、患者転帰の改善に対する需要の高まりに後押しされた技術進歩は、重要な技術革新をさらにもたらします。
  • コンポーネント別では、ソフトウェアソリューション部門が2024年の収益シェア45.81%で市場を独占し、予測期間中最も速い成長率が見込まれます。
  • 神経分野は2024年に24.09％の大きな売上シェアを占めました。
  • 腫瘍学分野は予測期間中に最も速いCAGRで成長する見込みです。
  • 北米の人工知能診断市場は2024年に54.74％の最大シェアで支配的でした。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 診断市場における人工知能の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場ドライバー分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 診断市場分析ツールにおける人工知能
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響
  • ケーススタディ

第4章 診断における人工知能市場：コンポーネントの推定・動向分析

  • コンポーネント市場シェア、2024年および2030年
  • セグメントダッシュボード
  • 診断における人工知能の世界市場：コンポーネント別展望
  • ソフトウェア
  • ハードウェア
  • サービス

第5章 診断における人工知能市場：診断の推定・動向分析

  • 診断市場シェア、2024年および2030年
  • セグメントダッシュボード
  • 診断における人工知能の世界市場：診断別展望
  • 心臓病学
  • 腫瘍学
  • 病理学
  • 放射線科
  • 胸部と肺
  • 神経学
  • その他

第6章 診断における人工知能市場：地域推定・動向分析、コンポーネント別、診断別

  • 地域別市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模、予測動向分析、2018年から2030年まで：
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • イノベーター
  • ベンダー情勢
    • 主要企業の市場シェア分析、2024年
    • Siemens Healthineers
    • Zebra Technologies Corp.
    • Riverain Technologies
    • Vuno, Inc.
    • Aidoc
    • NovaSignal Corporation（previously known as Neural Analytics, acquired by NeuraSignal, Inc.）
    • Imagen
    • Digital Diagnostics, Inc.
    • GE Healthcare
    • AliveCor Inc.
    • F. Hoffmann-La Roche Ltd
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 4 Global Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 5 North America Artificial Intelligence In Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 7 North America Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 8 U.S. Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 9 U.S. Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 10 Canada Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 11 Canada Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 12 Mexico Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 13 Mexico Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 14 Europe Artificial Intelligence In Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 16 Europe Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 17 UK Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 18 UK Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 19 Germany Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 20 Germany Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 21 France Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 22 France Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 23 Italy Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 24 Italy Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 25 Spain Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 26 Spain Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 27 Norway Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 28 Norway Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 29 Denmark Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 30 Denmark Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 31 Sweden Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 32 Sweden Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Artificial Intelligence In Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 36 Japan Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 37 Japan Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 38 China Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 39 China Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 40 India Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 41 India Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 42 Australia Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 43 Australia Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 44 South Korea Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 45 South Korea Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 46 Thiland Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 47 Thailand Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 48 Latin America Artificial Intelligence In Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 50 Latin America Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 51 Brazil Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 52 Brazil Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 53 Argentina Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 54 Argentina Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Artificial Intelligence In Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 58 South Africa Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 59 South Africa Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 62 UAE Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 63 UAE Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Artificial Intelligence In Diagnostics Market, by component, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Artificial Intelligence In Diagnostics Market, by diagnosis, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 PESTLE analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Artificial Intelligence In Diagnostics Market: Component outlook and key takeaways
  • Fig. 15 Artificial Intelligence In Diagnostics Market: Component movement analysis
  • Fig. 16 Software market, 2018 - 2030 (USD Million)
  • Fig. 17 Hardware market, 2018 - 2030 (USD Million)
  • Fig. 18 Services market, 2018 - 2030 (USD Million)
  • Fig. 19 Artificial Intelligence In Diagnostics Market: Diagnosis outlook and key takeaways
  • Fig. 20 Artificial Intelligence In Diagnostics Market: Diagnosis movement analysis
  • Fig. 21 Cardiology market, 2018 - 2030 (USD Million)
  • Fig. 22 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 23 Pathology market, 2018 - 2030 (USD Million)
  • Fig. 24 Radiology market, 2018 - 2030 (USD Million)
  • Fig. 25 Chest and lung market, 2018 - 2030 (USD Million)
  • Fig. 26 Neurology market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2024 & 2030
  • Fig. 30 Artificial Intelligence In Diagnostics Market: Region movement analysis
  • Fig. 31 North America Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 32 US Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Mexico Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Europe Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 39 UK Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Germany Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 France Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Italy Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Norway Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamic
  • Fig. 53 Sweden Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Asia Pacific Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 India Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Latin America Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Middle East and Africa Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait Artificial Intelligence In Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Company categorization
  • Fig. 83 Strategy mapping
  • Fig. 84 Company market position analysis
目次
Product Code: GVR-4-68038-871-8

Artificial Intelligence In Diagnostics Market Growth & Trends:

The global artificial intelligence in diagnostics market size is expected to reach USD 5.44 billion in 2030 and is expected to grow at a CAGR of 22.46% during the forecast period, according to a new report by Grand View Research, Inc. The growing demand for integrating AI-enabled algorithms in diagnostics to provide precise and accurate diagnosis at the earliest, which enhances clinical and operational outcomes, is driving the growth of this market. The rapidly growing cases of acute & chronic disorders across the globe are driving the demand for AI-based solutions since most of these ailments could be either prevented or delayed if diagnosed early and given appropriate treatments. The shortage of healthcare personnel is also supporting the product demand.

The emergence of startups, increasing funding opportunities, and growing public-private partnerships are also boosting market growth. Furthermore, medical technology is witnessing significant transitions & transformations and is rapidly adopting advanced AI-powered solutions to provide precise diagnosis, which enables care providers to design adequate treatment plans. Radiology and pathology are widely implementing AI-based algorithms & solutions and have provided proven results. In radiology, these solutions use information collected from multiple modalities to create image datasets to run data analysis, which could be used by the radiologist in delivering an accurate and timely diagnosis. Similarly, in pathology, these solutions could be integrated to run data analysis and provide accurate results.

The growing burden of chronic conditions across the global population is also driving the demand for AI-based diagnostic solutions. The key participants in AI in diagnostics market are focusing on the development of new, innovative products and the expansion of their business offerings to gain a competitive edge over others. In addition, many startups specializing in the development of advanced AI-based technologies are receiving favorable support and funding opportunities. This will also have a positive impact on the overall market growth. For instance, in September 2018, IDx received funding of USD 33 million from Optum Ventures and 8VC and the company will use this funding for the development of innovative AI-based solutions.

Artificial Intelligence In Diagnostics Market Report Highlights:

  • Technological advancements driven by the increasing demand for early and accurate disease detection, improving patient outcomes, further results in significant innovations.
  • Based on components, the software solutions segment dominated the market with a revenue share of 45.81% in 2024 and is expected to witness the fastest growth rate during the forecast period.
  • Neurology had a significant revenue share of 24.09% in 2024.
  • The oncology segment is expected to grow at the fastest CAGR during the forecast period.
  • North America artificial intelligence in diagnostics market dominated in 2024 with the largest share of 54.74%.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Component
    • 1.1.2. Diagnosis
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. Diagnosis outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Intelligence In Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Artificial Intelligence In Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. COVID-19 Impact
  • 3.4. Case Study

Chapter 4. Artificial Intelligence In Diagnostics Market: Component Estimates & Trend Analysis

  • 4.1. Component Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Artificial Intelligence In Diagnostics Market by Component Outlook
  • 4.4. Software
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Artificial Intelligence In Diagnostics Market: Diagnosis Estimates & Trend Analysis

  • 5.1. Diagnosis Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Artificial Intelligence In Diagnostics Market by Diagnosis Outlook
  • 5.4. Cardiology
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Pathology
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Radiology
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.8. Chest and Lung
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.9. Neurology
    • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Artificial Intelligence In Diagnostics Market: Regional Estimates & Trend Analysis, By Component, By Diagnosis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Innovators
  • 7.4. Vendor Landscape
    • 7.4.1. Key company market share analysis, 2024
    • 7.4.2. Siemens Healthineers
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Technology Type benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Zebra Technologies Corp.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Technology Type benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Riverain Technologies
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Technology Type benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Vuno, Inc.
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Technology Type benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Aidoc
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Technology Type benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. NovaSignal Corporation (previously known as Neural Analytics, acquired by NeuraSignal, Inc.)
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Technology Type benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Imagen
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Technology Type benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Digital Diagnostics, Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Technology Type benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. GE Healthcare
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Technology Type benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. AliveCor Inc.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Technology Type benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. F. Hoffmann-La Roche Ltd
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Technology Type benchmarking
      • 7.4.12.4. Strategic initiatives